Table 1 Precision, accuracy and recovery data of fructose-based 3-acetyl-2,3-dihydro- 1,3,4-oxadiazole (GLB) detected by high performance liquid chromatography (HPLC) method in rat plasma (Mean ± SD, n = 5).

From: Quantitative and qualitative analysis of the novel antitumor 1,3,4-oxadiazole derivative (GLB) and its metabolites using HPLC-UV and UPLC-QTOF-MS

Actual concentration (μg/mL)

Measured concentration (μg/mL)

Precision (RSD, %)

Accuracy (RE, %)

Recovery (%)

Intra-day

 0.025

0.028 ± 0.002

7.23

12.1

101

 0.5

0.506 ± 0.019

3.73

1.24

96.5

 4

4.055 ± 0.120

2.97

1.38

97.4

Inter-day

 0.025

0.026 ± 0.002

7.46

3.20

108

 0.5

0.509 ± 0.011

2.09

1.84

97.1

 4

4.108 ± 0.129

3.14

2.70

99.8

  1. RSD: relative standard deviation (%); RE: relative error (%).